Nick Stone | Head, Global Investor Relations |
Emma Walmsley | CEO & Director |
Tony Wood | Chief Scientific Officer |
Luke Miels | Chief Commercial Officer |
Deborah Waterhouse | CEO, ViiV Healthcare |
Iain Mackay | CFO & Executive Director |
James Gordon | JPMorgan Chase & Co. |
Simon Baker | Redburn |
Richard Parkes | BNP Paribas Exane |
Emmanuel Papadakis | Deutsche Bank |
Stephen Scala | Cowen and Company |
Peter Welford | Jefferies |
Timothy Anderson | Wolfe Research |
Emily Field | Barclays Bank |
Kerry Holford | Berenberg |
Michael Leuchten | UBS |
Graham Parry | Bank of America Merrill Lynch |
Andrew Baum | Citi |
Jo Walton | Crédit Suisse |
Keyur Parekh | Goldman Sachs |
Good afternoon, ladies and gentlemen, and welcome to the Analyst Call for the GSK Third Quarter 2022 Results. I will now hand you over to Nick Stone, Head of Global Investor Relations, who will introduce today's session. Nick, please go ahead.
Thank you, operator. Hello, everyone.